Advertisement

Rheumatology International

, Volume 5, Issue 4, pp 155–161 | Cite as

Spontaneous and aggregated IgG induced rheumatoid factor producing cells in rheumatoid arthritis

  • E. J. Pisko
  • R. A. Turner
  • M. Panetti
  • S. L. Foster
  • E. Heise
Originals

Summary

Seropositive rheumatoid arthritis (RA) patients were found to have high numbers of spontaneously occurring cells making rheumatoid factor (RF) reactive with human IgG as measured by a RF plaque forming cell (RF-PFC) assay. There was a significant positive correlation between the number of RF-PFC and both disease activity measured by the sedimentation rate and RF titer measured by the RA latex test. Aggregated IgG and pokeweed mitogen were equally effective stimulators of RF-PFC in cultures of RA peripheral blood mononuclear leukocytes. The rheumatoid ratio of helper (T4): suppressor (T8) T lymphocytes was also significantly increased over the ratio of normal controls, but this ratio did not correlate with the number of RF-PFC. Aggregated IgG or immune complexes may be responsible for stimulating RA RF-PFC in vivo.

Key words

Rheumatoid arthritis Rheumatoid factor Helper: Suppressor T lymphocytes Immune complexes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Vaughan JH, Tadao C, Moore TL, Robbins DL, Tanomoto K, Johnson JS, McMillan R (1976) Rheumatoid factor-producing cells detected by direct hemolytic plaque assay. J Clin Invest 58:933–941Google Scholar
  2. 2.
    Taylor-Upsahl MM, Abrahamsen TG, Natvig JB (1977) Rheumatoid factor plaque-forming cells in rheumatoid synovial tissue. Clin Exp Immunol 28:197–203Google Scholar
  3. 3.
    Egeland T, Lea T, Saari G, Mellbye OJ, Natvig JB (1982) Quantitation of cells secreting rheumatoid factor of IgG, IgA, and IgM class after elution from rheumatoid synovial tissue. Arthritis Rheum 25:1445–1450Google Scholar
  4. 4.
    Pisko E, Panetti M, Foster S, Turner RA (1983) Human rheumatoid factor producing cell induction by 2-mercaptoethanol: Immunomodulation by simple thiol compound. Int J Immunopharmacol 5:163–171Google Scholar
  5. 5.
    Koopman WJ, Schrohenloher RE (1980) In vitro synthesis of IgM rheumatoid factor by lymphocytes from healthy adults. J Immunol 125:934–939Google Scholar
  6. 6.
    Koopman WJ, Schrohenloher RE (1980) Enhanced in vitro synthesis of IgM rheumatoid factor in rheumatoid arthritis. Arthritis Rheum 23:985–992Google Scholar
  7. 7.
    Tsoukas CD, Carson DA, Fong S, Pasquali JL, Vaughan JH (1980) Cellular requirements for pokeweed mitogen-induced autoantibody production in rheumatoid arthritis. J Immunol 124:1125–1129Google Scholar
  8. 8.
    Olsen N, Ziff M, Jasin HE (1982) In vitro synthesis of immunoglobulins and IgM-rheumatoid factor by blood mononuclear cells of patients with rheumatoid arthritis. Rheumatol Int 2:59–66Google Scholar
  9. 9.
    Patel V, Panayi GS, Unger A (1983) Spontaneous and pokeweed mitogen induced in vitro immunoglobulin and IgM rheumatoid factor production by peripheral blood and synovial fluid mononuclear cells in rheumatoid arthritis. J Rheumatol 10:364–372Google Scholar
  10. 10.
    Slaughter L, Carson DA, Jensen FC, Holbrook TL, Vaughan JH (1980) In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med 148:1429–1434Google Scholar
  11. 11.
    Dresser DW (1978) Most IgM-producing cells in the mouse secrete auto-antibodies (rheumatoid factor). Nature 274:480–482Google Scholar
  12. 12.
    Izui A, Eisenberg RA, Dixon FJ (1979) IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J Immunol 125:2096–2102Google Scholar
  13. 13.
    Pisko EJ, Foster SL, Turner RA (1981) Induction of autoantibody-producing cells after the coculture of haptenated and normal human mononuclear leukocytes. Proc Soc Exp Biol Med 168:131–136Google Scholar
  14. 14.
    Pisko EJ, Turner RA, Foster SL (1982) Induction of human rheumatoid factor producing cells by aggregated IgG. Arthritis Rheum 25:1108–1116Google Scholar
  15. 15.
    Winchester RJ, Agnello V, Kunkel HB (1970) Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis: partial characterization and relationship to lower complement levels. Clin Exp Immunol 6:689–706Google Scholar
  16. 16.
    Hannestad K (1967) Presence of aggregated γ-G-globulin in certain rheumatoid synovial effusions. Clin Exp Immunol 2:511–529Google Scholar
  17. 17.
    Winchester RJ, Kunkel HG, Agnello V (1971) Occurrence of gamma globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration. J Exp Med 134:286 s-295 sGoogle Scholar
  18. 18.
    Zubler RH, Nydegger V, Perrin LH, Fehr K, McCormick J, Lambert PH, Miescher PA (1976) Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological fetures of the disease. J Clin Invest 57:1308–1319Google Scholar
  19. 19.
    Nishmimaki T, Kyoichi K, Milgrom F (1978) Studies on immune complexes in rheumatoid arthritis. Arthritis Rheum 21:639–644Google Scholar
  20. 20.
    Munthe E, Natvig JB (1971) Characterization of IgG complexes in eluates from rheumatoid tissue. Clin Exp Immunol 8:249–262Google Scholar
  21. 21.
    Bell DA (1979) Cell-mediated immunity in rheumatoid arthritis and systemic lupus erythematosus: too little or too much? J Rheumatol 6:484–488Google Scholar
  22. 22.
    Bresnihan B, Jasin HE (1977) Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest 59:106–116Google Scholar
  23. 23.
    Keystone EC, Gladman DG, Buchanan R, Cane D, Poplonski (1980) Impaired antigen-specific suppressor activity in patients with rheumatoid arthritis. Arthritis Rheum 23:1246–1250Google Scholar
  24. 24.
    Smolen JS, Lanzer G, Scherak O, Menzel EJ, Mayr WR, Steffen C, Knapp W (1981) Concanavalin A-induced suppressor cell activity and in vitro immunoglobulin secretion in rheumatoid arthritis; correlation with clinical and immunological parameters. Rheumatol Int 1:115–120Google Scholar
  25. 25.
    Abdou NI, Lindsley HB, Racela LS, Pascual E, Hassanein KM (1981) Suppressor T cell dysfunction and anti-suppressor cell antibody in active early rheumatoid arthritis. J Rheumatol 8:9–18Google Scholar
  26. 26.
    Fox RI, Fung S, Sabharwal N, Carstens SA, Kung PC, Vaughan JH (1982) Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol 128:351–354Google Scholar
  27. 27.
    Duclos M, Zeidler H, Liman W, Pichler WJ, Rieber P, Peter HH (1982) Characterization of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and Acid α-napthyl esterase staining. Rheumatol Int 2:75–82Google Scholar
  28. 28.
    Veys EM, Hermanns P, Goldstein G, Kung P, Schindler J, Van Wauwe J (1981) Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents. Int J Immunopharmacol 3:313–320Google Scholar
  29. 29.
    Veys EM, Hermanns P, Schindler J, Kung PC, Goldstein G, Symoens J, Van Wauwe J (1982) Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis. J Rheumatol 9:25–29Google Scholar
  30. 30.
    Bellamy N, Cairns E, Bell DA (1983) Immunoregulation in rheumatoid arthritis: Evaluation of T lymphocyte function in the control of polyclonal immunoglobulin synthesis in vitro. J Rheumatol 10:19–27Google Scholar
  31. 31.
    Ropes MW, Bennett GA, Cobb F, Jacox R, Jessar R (1958) Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 97:175–176Google Scholar
  32. 32.
    Böyum A (1962) Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest (Suppl 97) 21:77–89Google Scholar
  33. 33.
    Dosch HM, Gelfand EW (1976) In vitro induction and measurement of hemolytic plaque-forming cells in man. J Immunol Methods 11:107–116Google Scholar
  34. 34.
    Dosch HM, Gelfand EW (1977) Generation of human plaqueforming cells in culture: tissue distribution, antigenic and cellular requirements. J Immunol 118:302–308Google Scholar
  35. 35.
    Sweet GH, Welborn FL (1971) Use of chromium chloride as the coupling agent in a modified plaque assay for cells producing anti-protein antibody. J Immunol 106:1407–1410Google Scholar
  36. 36.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275Google Scholar
  37. 37.
    Singer JM, Plotz CM (1956) The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med 21:888–892Google Scholar
  38. 38.
    Waaler E (1940) On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 17:172–188Google Scholar
  39. 39.
    Rose HM, Ragan C, Pearce E, Lipman MO (1948) Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med 68:1–6Google Scholar
  40. 40.
    Fröland SS (1972) Binding of sheep erythrocytes to human lymphocytes. A probable marker of T lymphocytes. Scand J Immunol 1:269–280Google Scholar
  41. 41.
    Reinhertz EL, Kung PC, Goldstein G, Schlossman SF (1979) Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol 126:2894–2896Google Scholar
  42. 42.
    Robbins DL, Moore TL, Carson DA, Vaughan JH (1978) Relative reactivities of rheumatoid factor in serum and cells. Arthritis Rheum 21:820–826Google Scholar
  43. 43.
    Yamasaki K, Ziff M (1977) Enhancement of in vitro immunoglobulin synthesis of rheumatoid lymphocytes by aggregated human gamma globulin. Arthritis Rheum 20:679–684Google Scholar
  44. 44.
    Morgan EL, Weigle WO (1980) Aggregated human γ-globulin induced proliferation and polyclonal activation of murine B lymphocytes. J Immunol 125:226–231Google Scholar
  45. 45.
    Morgan EL, Shield JE, Campbell CS, Barton RL, Koppel GA, Weigle WO (1983) Synthetic Fc peptide-mediated regulation of the immune response I. Characterization of the immunomodulating properties of a synthetic 23-amino acid peptide derived from the sequence of the CH3 domain of human IgG1. J Exp Med 157:947–956Google Scholar
  46. 46.
    Thoman ML, Morgan EL, Weigle WO (1981) Fc fragment activation of T lymphocytes. I. Fc fragments trigger Lyt 1+23T lymphocytes to release a helper T cell-replacing activity. J Immunol 126:632–635Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • E. J. Pisko
    • 1
  • R. A. Turner
    • 1
  • M. Panetti
    • 1
  • S. L. Foster
    • 1
  • E. Heise
    • 2
  1. 1.Section on Rheumatology, Department of MedicineBowman Gray School of Medicine of Wake Forest UniversityWinston-SalemUSA
  2. 2.Department of Microbiology/ImmunologyBowman Gray School of Medicine of Wake Forest UniversityWinston-SalemUSA

Personalised recommendations